HKEX halves listing thresholds to lure WVR companies, overseas issuers

The Stock Exchange of Hong Kong lowered the market cap threshold for weighted voting rights listings to HKD20 billion from HKD40 billion and relaxed the maximum voting ratio to 20:1, the bourse said in consultation conclusions published Wednesday.

"The reforms are designed to enhance the competitiveness of Hong Kong's listing regime and broaden access for innovative companies," the exchange said. All proposals received broad support from the 73 market submissions and were fully adopted after minor amendments.

For companies with at least HKD40 billion in market cap at listing, the WVR ratio cap was doubled to 20:1 from 10:1. The shareholding requirement was cut to 5% from 10% for firms with holdings worth at least HKD4 billion. The exchange also expanded the definition of "innovative" companies to include those with innovative business models, not just technological innovation, with Biotech and Specialist Technology Companies presumed to qualify.

The changes take effect immediately and target a wave of Chinese tech and biotech companies that have chosen New York or Shanghai over Hong Kong due to its stricter WVR rules. CICC expects HKEX's second-quarter net profit to rise 13% year-on-year, according to a related note.

For secondary listings by overseas issuers, the exchange aligned financial eligibility thresholds for WVR applicants with those for primary listings. The market cap requirement for one-share-one-vote companies was reduced to HKD6 billion from HKD10 billion. The bourse also streamlined guidance for converting secondary listings to primary listings and provided additional guidance on compliance actions.

Initial listing requirements codified

The exchange codified continuity of ownership and control into the Listing Rules, specifying that applicants can still qualify if they demonstrate ownership changes during the relevant period did not materially alter influence over company management. The permitted scope for US GAAP was expanded to cover subsidiaries of US-listed parent companies and companies with substantial US operations.

Commercialized Biotech Companies or Specialist Technology Companies may now choose to apply for listing under special chapters. All new applicants may submit listing applications confidentially, a move that aligns Hong Kong with US and Singapore practices where companies can test market reception before public disclosure.

What the reforms mean for Hong Kong's IPO pipeline

The rule changes address a competitive disadvantage that has cost Hong Kong several high-profile tech listings. The new 20:1 voting ratio and 5% shareholding threshold bring the exchange closer to the flexibility offered by the New York Stock Exchange and Nasdaq. The HKD6 billion market cap threshold for one-share-one-vote secondary listings represents a 40% reduction from the previous HKD10 billion requirement, potentially accelerating the return of US-listed Chinese companies seeking a second home in Hong Kong.

This article is for informational purposes only and does not constitute investment advice.